3
Views
0
CrossRef citations to date
0
Altmetric
Cardiovascular Agents (Including Blood Products)

Patent Evaluation: Class III Anti-Arrhythmic Agents with Positive Inotropic Activity

Pages 88-89 | Published online: 02 Mar 2011
 

Summary

Novelty: Pyrimidinedione derivatives which are claimed to be effective in the treatment of cardiac arrhythmias are disclosed.

Biology: Myocardial action potential duration time (APD75) effects are measured in an assay using hybrid adult dog heart as described previously (results are tabulated).

Chemistry: The synthesis is by standard techniques. Fifteen compounds are exemplified by synthesis. 1,3-Dimethyl-6-[4-(2-hydroxy-4-phenylbutyl)piperazin-1-yl]-2,4-(1H,3H)-pyrimidinedione hydrochloride is the preferred compound.

Structure:

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.